Orchestra BioMed Holdings Inc. Financial Flexibility Index
Orchestra BioMed Holdings Inc. financial flexibility index. Orchestra BioMed Holdings Inc. (OBIO) has a Financial Flexibility Index of -0.22x as of June 2026. Free cash flow of $-19.08 Million (operating CF $-19.33 Million minus capex $254.00K) represents 0% of total liabilities ($86.28 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Orchestra BioMed Holdings Inc. (2020–2025)
Financial flexibility index of Orchestra BioMed Holdings Inc. from 2020 to 2025. Historical Financial Flexibility Index trend for Orchestra BioMed Holdings Inc. across 6 annual periods. Check Orchestra BioMed Holdings Inc. (OBIO) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Orchestra BioMed Holdings Inc. Financial Flexibility Index by Year (2020–2025)
Orchestra BioMed Holdings Inc. financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Orchestra BioMed Holdings Inc.. For the full cash flow conversion analysis, see how efficiently does Orchestra BioMed Holdings Inc. generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.94x | $-48.47 Million | $-48.96 Million | $51.48 Million | ▲ +19.1% |
| 2024 | -1.16x | $-50.27 Million | $-50.56 Million | $43.22 Million | ▲ +31.4% |
| 2023 | -1.69x | $-46.05 Million | $-46.13 Million | $27.17 Million | ▼ -154.2% |
| 2022 | -0.67x | $-28.70 Million | $-29.29 Million | $43.04 Million | ▼ -195.1% |
| 2021 | -0.23x | $-19.16 Million | $-19.43 Million | $84.76 Million | ▲ +23.7% |
| 2020 | -0.30x | $-25.64 Million | $-26.18 Million | $86.63 Million | — |